Press Releases :: CV Sciences, Inc. (CVSI)

Investors

Investors

CV Sciences is a consumer wellness company specializing in nutraceuticals and plant-based foods.

Press Releases

CV SCIENCES, INC. TO ANNOUNCE SECOND QUARTER 2022 RESULTS ON AUGUST 15, 2022

Aug 9, 2022

CV Sciences, Inc. Reports First Quarter 2022 Financial Results

May 16, 2022

CV Sciences, Inc. to Announce First Quarter 2022 Results On May 16, 2022

May 12, 2022

CV Sciences, Inc. Reports Fiscal Year-End 2021 Financial Results

Mar 31, 2022

CV Sciences, Inc. to Announce Fourth Quarter and Full Year 2021 Results on March 31, 2022

Mar 28, 2022

UPDATE -- CV Sciences Adds +PlusCBD Relief Softgels to Wellness Line of CBD Products

Mar 11, 2022

CV Sciences Adds +PlusCBD Relief Softgels to Wellness Line of CBD Products

Mar 8, 2022

CV Sciences, Inc. Announces Launch of +PlusCBD™ Pain Relief Topicals

Jan 11, 2022

CV Sciences, Inc. Announces New Distribution Agreement with GNC

Jan 5, 2022

CV Sciences, Inc. Appoints Haskell & White LLP as Auditor

Nov 30, 2021